103 related articles for article (PubMed ID: 20110641)
1. Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement.
Donghi D; Mainetti C
Dermatology; 2010; 220(3):282-6. PubMed ID: 20110641
[No Abstract] [Full Text] [Related]
2. Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet Disease (ABD).
Boura P; Tselios K; Kamali S; Skendros P; Sarantopoulos A; Topouzis F
Neurol Sci; 2006 Dec; 27(6):432-5. PubMed ID: 17205230
[TBL] [Abstract][Full Text] [Related]
3. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Tabbara KF; Al-Hemidan AI
Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
[TBL] [Abstract][Full Text] [Related]
4. Behçet disease presenting with frosted branch angiitis.
Jackson TE; Pathak S; Doran RM
Ocul Immunol Inflamm; 2011 Feb; 19(1):65-6. PubMed ID: 21034306
[TBL] [Abstract][Full Text] [Related]
5. Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease.
Sfikakis PP; Kaklamanis PH; Elezoglou A; Katsilambros N; Theodossiadis PG; Papaefthimiou S; Markomichelakis N
Ann Intern Med; 2004 Mar; 140(5):404-6. PubMed ID: 14996689
[No Abstract] [Full Text] [Related]
6. Adamantiades-Behcet disease: diagnosis and current concepts in management of ocular manifestations.
Durrani K; Ahmed M; Foster CS
Compr Ophthalmol Update; 2007; 8(4):225-33. PubMed ID: 17999836
[TBL] [Abstract][Full Text] [Related]
7. Headache from cavernous sinus thrombosis in Adamantiades-Behçet disease.
Efthimiou P; Petryna O
J Clin Rheumatol; 2010 Dec; 16(8):409. PubMed ID: 21119387
[No Abstract] [Full Text] [Related]
8. Successful use of infliximab in a patient with neuro-Behçet's disease.
Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
[TBL] [Abstract][Full Text] [Related]
9. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease.
Benseler SM; deVeber G; Hawkins C; Schneider R; Tyrrell PN; Aviv RI; Armstrong D; Laxer RM; Silverman ED
Arthritis Rheum; 2005 Jul; 52(7):2159-67. PubMed ID: 15986347
[TBL] [Abstract][Full Text] [Related]
10. [The involvement of the parenchyma of the central nervous system in Behçet disease].
Martínez-Yélamos A; Vidaller A; Mitjavila F; Pujol R; Jato M; Rubio F
Rev Neurol; 1998 Aug; 27(156):223-5. PubMed ID: 9736951
[TBL] [Abstract][Full Text] [Related]
11. Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
Kram MT; May LD; Goodman S; Molinas S
Dis Colon Rectum; 2003 Jan; 46(1):118-21. PubMed ID: 12544532
[TBL] [Abstract][Full Text] [Related]
12. Refractory primary central nervous system vasculitis of childhood: successful treatment with infliximab.
Batthish M; Banwell B; Laughlin S; Halliday W; Peschken C; Paras E; Benseler S
J Rheumatol; 2012 Nov; 39(11):2227-9. PubMed ID: 23118297
[No Abstract] [Full Text] [Related]
13. Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
Licata G; Pinto A; Tuttolomondo A; Banco A; Ciccia F; Ferrante A; Triolo G
Ann Rheum Dis; 2003 Mar; 62(3):280-1. PubMed ID: 12594127
[No Abstract] [Full Text] [Related]
14. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
[No Abstract] [Full Text] [Related]
15. [Pseudotumoral neurobehçet: a case report].
Ben Taarit C; Turki S; Ben Maïz H
J Mal Vasc; 2002 Apr; 27(2):93-5. PubMed ID: 12015487
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
[No Abstract] [Full Text] [Related]
17. Infliximab as an alternative treatment for Behçet disease when other therapies fail.
Ugras M; Ertem D; Celikel C; Pehlivanoglu E
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):212-5. PubMed ID: 18223383
[No Abstract] [Full Text] [Related]
18. MRI findings in pediatric neuro-Behçet's disease.
Saltik S; Saip S; Kocer N; Siva A; Yalçinkaya C
Neuropediatrics; 2004 Jun; 35(3):190-3. PubMed ID: 15248102
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of the distribution of major histocompatibility system antigens in retinal vasculitis in patients with Behçet's disease].
Ermakova NA
Vestn Oftalmol; 2003; 119(1):31-3. PubMed ID: 12608042
[TBL] [Abstract][Full Text] [Related]
20. [Frosted-branch angiitis revealing Behçet's disease].
Renard E; Chiquet C; Bouillet L; Romanet JP
J Fr Ophtalmol; 2009 Nov; 32(9):664-8. PubMed ID: 19616344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
